Avanos Medical (AVNS) Receivables - Net (2013 - 2026)

Avanos Medical has disclosed Receivables - Net across 14 years of filings, most recently posting $106.3 million for Q1 2026.

• In Q1 2026, Receivables - Net fell 3.28% year-over-year to $106.3 million; the TTM figure through Mar 2026 stood at $106.3 million (down 3.28% YoY), while the FY2025 annual figure was $108.0 million, down 19.16% from the prior year.
• Receivables - Net came in at $106.3 million for Q1 2026 at Avanos Medical, down from $108.0 million in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $167.9 million in Q4 2022 to a low of $106.3 million in Q1 2026.
• Average Receivables - Net over 5 years is $134.7 million, with a median of $137.3 million recorded in 2024.
• Year-over-year, Receivables - Net soared 47.58% in 2022 and fell 19.16% in 2025.
• Over 5 years, Receivables - Net stood at $167.9 million in 2022, then slipped by 14.95% to $142.8 million in 2023, then retreated by 6.44% to $133.6 million in 2024, then declined by 19.16% to $108.0 million in 2025, then dropped by 1.57% to $106.3 million in 2026.
• Per Business Quant data, the three most recent Receivables - Net figures were $106.3 million in Q1 2026, $108.0 million in Q4 2025, and $116.0 million in Q3 2025.